Literature DB >> 10094126

Early visual processing during binocular rivalry studied with visual evoked potentials.

F Valle-Inclán1, S A Hackley, C de Labra, A Alvarez.   

Abstract

Visual evoked potentials (VEPs) were recorded to probes presented to the dominant and suppressed eyes in a binocular rivalry paradigm. Probes presented to the suppressed eye interrupted the current dominance phase and produced a P300-like deflection (400-700 ms). Probes delivered to the dominant eye increased the duration of the current dominance phase. VEPs to these probes included an endogenous component that overlapped the early exogenous components. The early endogenous component (rivalry-related potential, RRP) started as early as 70 ms and had a broad centroparietooccipital distribution.

Entities:  

Mesh:

Year:  1999        PMID: 10094126     DOI: 10.1097/00001756-199901180-00004

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  Regulating the Access to Awareness: Brain Activity Related to Probe-related and Spontaneous Reversals in Binocular Rivalry.

Authors:  Brian A Metzger; Kyle E Mathewson; Evelina Tapia; Monica Fabiani; Gabriele Gratton; Diane M Beck
Journal:  J Cogn Neurosci       Date:  2017-02-14       Impact factor: 3.225

2.  Compatibility between stimulated eye, target location and response location.

Authors:  Andrea Schankin; Fernando Valle-Inclán; Steven A Hackley
Journal:  Psychol Res       Date:  2009-06-12

3.  Endogenous attention selection during binocular rivalry at early stages of visual processing.

Authors:  Jyoti Mishra; Steven A Hillyard
Journal:  Vision Res       Date:  2008-04-01       Impact factor: 1.886

4.  Probing the mechanisms of probe-mediated binocular rivalry.

Authors:  Brian A Metzger; Diane M Beck
Journal:  Vision Res       Date:  2020-05-20       Impact factor: 1.886

5.  On the role of attention in binocular rivalry: electrophysiological evidence.

Authors:  Urte Roeber; Sandra Veser; Erich Schröger; Robert P O'Shea
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.